PatientSky WKN: A2QFW9 ISIN: NO0010895667 Forum: Aktien User: Kölner0816

Na dann Glückwunsch zu den schnellen 20% Minus

Ja, ärgerlich. Bei 1% Depotgröße aber verkraftbar. Option auf bessere Kurse besteht aber nach wie vor. Ebenso auf schlechtere... will see

Bin auch dabei 👌🏻😬

Momentum scheint wieder zu drehen

Gab's News?

Updated 2021 revenue and EBITDA guidance 07.07.2021 12:53 https://newsweb.oslobors.no/message/537676 PatientSky is revising it's 2021 revenue guidance down to NOK 205-210m from previously guidance of >NOK 240m. The decline from previous revenue guidance comes 2/3 from delayed PaaS revenues and 1/3 from lower SaaS revenues. The EBITDA-margin guidance is subsequently revised down to >20% from previous guidance of >25%. The Paas revenue revision of NOK 20m represents a 14% group revenue downgrade and is due to a delay in product development. We plan to onboard several of the +30 partners already in the pipeline with a fully scalable and commercial ready platform in 2022. The SaaS revenue revision of NOK 10-15m represents a 7-10% group revenue downgrade and stems from factors including commercial execution, PMI headwinds and churn. Particularly upselling of video and VOIP has proved more difficult as patients have been returning to physical visits as COVID restrictions and worries have eased. Despite the negative update, we remain positive for the ongoing transition to a more focused platform company. Recent important initiatives include organizing into business units, promoting a talented CCO PaaS and continuing to pursue our mission to deliver revolutionary and innovative eHealth solutions. We have identified and begun to address the key issues that need to be resolved and foresee an improved commercial situation heading into 2022 and beyond. For further information, please contact: CEO: Johan Zetterström

Eigentlich ist alles top, nur der Kurs nicht

so seit heute drin

Hoppla hier hat es aber gerappelt

ist ne Wette wert

Bin jetzt investiert

endlich ein Handelsupdate nach viel Stille seit der Notierung. * MRR 60% 2020 * Adj. EBITDA 170% * Leitfaden 70 % Umsatzwachstum 2021e!💥 * Im Jahr 2021 wird es weitere Akquisitionen geben, wenn diese in Strategie und Preis passen

Ich hab mir mal den Newsletter abonniert. Hoffe da kommt bald mal was. 😃

Gibt’s eigentlich irgendwelche News?

Bin jetzt auch mal dabei. Mal sehen, wann es wieder bergauf geht :)